![Hendrik-Tobias Arkenau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hendrik-Tobias Arkenau
Fondateur chez Sarah Cannon Research Institute UK Ltd.
Postes actifs de Hendrik-Tobias Arkenau
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Directeur Technique/Scientifique/R&D | 01/01/1993 | - |
Fondateur | 01/01/1993 | - |
Historique de carrière de Hendrik-Tobias Arkenau
Statistiques
Internationale
Royaume-Uni | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorielle
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Commercial Services |
- Bourse
- Insiders
- Hendrik-Tobias Arkenau
- Expérience